The impact of COVID-19 non-pharmaceutical interventions on HIV care continuum in China: An interrupted time series analysisResearch article Published on 2022-12-012022-10-05 Journal: The Lancet Regional Health - Western Pacific [Category] 변종, [키워드] 95% CI affected Analysis Antiretroviral therapy ART Care CD4 count CD4 counts CD4+ T cell China collected continuum COVID-19 decrease diagnose diagnoses Diagnosis disease early stage effort evaluate expected finding foundation funding HIV hospital implementation increase in Infectious disease Interrupted time series analysis interval Intervention maintain majority male median time natural non-pharmaceutical interventions (NPIs) NPI NPIs occurred outcome outcomes Poisson Prophylaxis public health emergency reached Region Regression model Science study period time interval time intervals Transmission were recorded [DOI] 10.1016/j.lanwpc.2022.100569 [Article Type] Research article
Comparison of maternal and neonatal outcomes of COVID-19 before and after SARS-CoV-2 omicron emergence in maternity facilities in Malawi (MATSurvey): data from a national maternal surveillance platformArticle Published on 2022-11-012022-11-16 Journal: The Lancet. Global health [Category] SARS, 변종, [키워드] Abstract adjusted age breath Clinical features COVID-19 death demographic demographic characteristics died enrolment event Fisher foundation health-care less Logistic regression material Maternal Melinda Gate National Neonatal Neonate Odds ratio outcome pandemic Patient platform Pregnancy pregnant pregnant patients reported SARS-CoV-2 SARS-COV-2 infection second wave Stillbirth sub-Saharan Africa Surveillance Symptom symptomatic symptoms of COVID-19 the SARS-CoV-2 translation Wellcome Trust [DOI] 10.1016/S2214-109X(22)00359-X PMC 바로가기
An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patientsArticle Published on 2022-10-052022-11-16 Journal: eLife [Category] COVID19(2023년), SARS, 변종, [키워드] adjusted analysis Analysis Appendix approach assumption available data Calabria carrier caused changes in characterisation clinical Clinical outcome Clinical research clinical study collected Commonwealth confidence interval confounders COVID-19 dataset DAVID development Donor emergence Epidemiology European European Commission fatality Foreign foundation Frequency funding global health Google.org group heterogeneity Horizon hospital hospitalised hospitalised patient Imperial College London include infecting Infection Infectious disease International IRCCS ISARIC Italian Joshua less Logistic regression lower mortality Medical Research Council Medicine Melinda Gate Microbiology Ministry of Health network NIHR NIHR HPRU Odds ratio office omicron opportunity outcome Oxford Patient PHE protection Public Health England Rapid relative frequencies reported symptom Research respiratory response responsible Rockefeller Foundation SARS-CoV-2 variant School Semple sensitivity analysis Sriniva study population subset Support supported Symptoms union unit University of Liverpool University of Oxford variant variants viral genomic information viruses viruses. with COVID-19 [DOI] 10.7554/eLife.80556 PMC 바로가기
Changes in Care during the COVID-19 Pandemic for People with Cystic FibrosisArticle Published on 2022-10-012022-11-16 Journal: Annals of the American Thoracic Society [Category] 변종, [키워드] 95% CI 95% confidence interval age Ambulatory care BMI body mass index calculated Care change changed changes in children coronavirus disease COVID-19 COVID-19 pandemic Cystic cystic fibrosis effective eligible enrolled expiratory FEV foundation Lung function no difference Paired t test pandemic predicted proportion pulmonary exacerbation Pulmonary function pulmonary function. registry risk severe disease the mean transitioned transmembrane Volume [DOI] 10.1513/AnnalsATS.202105-532OC PMC 바로가기
Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patientsArticle Published on 2022-10-012022-11-16 Journal: The lancet. Psychiatry [Category] COVID19(2023년), SARS, 변종, [키워드] 1:1 Adults Affect age Alpha Analysis Anxiety Anxiety Disorder B.1.1.529 B.1.1.7 B.1.617.2 baseline Brain Bulgaria children cognitive Cohort cohort of patient cohorts cohorts of patient collected COVID-19 death rate Dementia Demographic factors diagnose diagnosed diagnosed with COVID-19 Diagnosis diagnosis of COVID-19 died disorder disorders Electronic health record epilepsy female Follow-up follow-up period foundation greater hazard ratio health-care health-care system help higher risk hospital HRs incidence increased risk India indicate individual Insomnia International ischaemic stroke less Malaysia male matching neurological Older other respiratory infections outcome outcomes Oxford Parkinsonism Pathogenesis Patient primary care profile proportion Psychiatric psychiatric diagnose psychiatric diagnosis psychiatric disorder reached recorded remained representing respiratory infection response retrospective cohort retrospective cohort study returned risk risk factor SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant Seizure Seizures severe COVID-19 illness significantly Spain stratified study period sustained Taiwan trajectory USA vaccination variant variants was done while with COVID-19 Wolfson [DOI] 10.1016/S2215-0366(22)00260-7 PMC 바로가기
Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19Research article Published on 2022-10-012022-10-05 Journal: International Journal of Environmental Research an [Category] COVID19(2023년), SARS, 바이오마커, 변종, 유전자 메커니즘, 임상, 진단, 치료기술, [키워드] 95% CI Activation adjusted adjusted odds ratio aggregation Alpha Analysis application B.1.1.7 Bath biochemical Biomarkers biomarkers of inflammation biopsy changes clinical factors clinical outcomes clinically Coagulation Cohort Complication correlation Council COVID-19 death develop Dexamethasone diagnostic Direct driving dysregulation of coagulation Engineering evaluated facilitate finding foundation funding hazard ratio heart hospital identify in-hospital mortality indicated Inflammation investigated mammary marker myocardial injury National Health Service NHS NIHR Non-invasive outcome Oxford parameters Pathways Patient patients with COVID-19 perivascular Platelet platform predict produced Prognostic value pulmonary angiography pulmonary CT representing respond responsible risk RNA sequencing data SARS-CoV-2 variant Science sensitivity analysis targeted therapy therapeutic target transcriptional transcriptomic Treatment Trial validation study variant vascular inflammation Wellcome Trust Whole blood wild-type SARS-CoV-2 with COVID-19 [DOI] 10.1016/S2589-7500(22)00132-7 [Article Type] Research article
A machine-learning algorithm for diagnosis of multisystem inflammatory syndrome in children and Kawasaki disease in the USA: a retrospective model development and validation studyArticle Published on 2022-10-012022-11-16 Journal: International Journal of Environmental Research an [Category] COVID19(2023년), SARS, 치료기술, [키워드] Accuracy age Algorithm Boston Care center characteristic Child childhood children clinician collected Connecticut COVID-19 pandemic develop development diagnosed Diagnosis Diego disease distribution Early detection enrolled Eunice Kennedy Shriver External feature febrile febrile illness first stage FIVE foundation group heart hospital hospitals Human illness illnesses Inflammatory initial IQR Kawasaki disease laboratory measurements library Los Angele machine-learning median Medicine MIS-C Patient Prevent retrospective SARS-COV-2 infection severe complications similarity stratified syndrome systemic inflammation Treatment USA validation study Washington [DOI] 10.1016/S2589-7500(22)00149-2 PMC 바로가기
COVID-19 from the perspective of otorhinolaryngology: An analysis of bibliometricsArticle Published on 2022-09-232022-11-15 Journal: Frontiers in Public Health [Category] SARS, 치료기술, [키워드] 2019 novel coronavirus Analysis analytics archive article articles authors bibliometric analysis citation CiteSpace clinical Collection core coronavirus coronavirus disease country COVID-19 COVID-19 research database detect disease Diseases European feature foundation globe highest index Jin manifestation Metrics MOST NHS original Otolaryngological manifestations Otorhinolaryngology otorhinolaryngology. outbreak pandemic Patient Perspective Quantitative Research SARS-CoV-2 Science Symptom Symptoms technology The United States Thoma Topic Trust university virus VOSviewer Web of Science Wuhan, China [DOI] 10.3389/fpubh.2022.1002686 PMC 바로가기
SARS-CoV-2 antibody dynamics in blood donors and COVID-19 epidemiology in eight Brazilian state capitals: A serial cross-sectional studyArticle Published on 2022-09-222022-11-15 Journal: eLife [Category] SARS, 변종, 진단, [키워드] age antibody waning attack rate Blood blood donor Blood donors Brazil circulating complex country COVID-19 COVID-19 situation CrI cross-sectional disease dominant Donor eight Epidemic Epidemics Epidemiology fatality Fatality rate Fazer foundation Gamma Gate global health health system heterogeneity highlight hospitalisation IFR IgG antibody Infection Infection fatality rate JBS Medical Research Council morbidity Older outbreak ranged respiratory pathogen SARS-CoV-2 SARS-CoV-2 antibody second wave sensitivity Seroprevalence Serosurveillance significantly Society specificity Spread supported tested understanding utility variant viruses viruses. VoC Weekly Wellcome Trust were used women [DOI] 10.7554/eLife.78233 PMC 바로가기
SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concernArticle Published on 2022-09-182022-10-06 Journal: EBioMedicine [Category] COVID19(2023년), SARS, 변종, 진단, 치료제, [키워드] absence ACE2 acute respiratory syndrome ADK antibody BA.2 BA.5 Beta BNT162b2 breadth Breakthrough infection cell line change circulating clade Clinical effect cohorts contributed convalescent convalescent sera coronavirus COVID-19 COVID-19 hospitalisation Delta development disease severity Donor donors dose foundation Future genetic difference greater humoral Humoral response IgG in vitro isolate Lineage lineages Live virus management monitoring monoclonal antibody mortality rates nafamostat nasopharyngeal sample nasopharyngeal swabs neutralisation neutralisation assay Neutralising Antibodies neutralising antibody New observation of BNT162b2 omicron Omicron BA.1 other variant pathway peak plasma potency recorded reduced reduction reduction in Research response responses SARS-CoV-2 sensitivity significantly Sotrovimab South Spread Support supported tested Testing therapeutic Therapies TMPRSS2 TMPRSS2 inhibitor TMPRSS2. Transmission utilised vaccination Vaccine variant viral lineage viral variant [DOI] 10.1016/j.ebiom.2022.104270 PMC 바로가기 [Article Type] Article